Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Bonnet

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Brain Research|January 1, 1986
Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's diseaseM Ruberg, F Rieger, A Villageois, et al.
Lancet (London, England)|March 17, 1979
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's diseaseY Agid, P Pollak, A M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical studyN Gouider-Khouja, M Vidailhet, A M Bonnet, et al.
Neurology|September 1, 1994
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?M Vidailhet, A M Bonnet, R Marconi, et al.
Advances in Neurology|January 1, 1993
Dementia in Parkinson's disease. Morphometric dataC Duyckaerts, P Gaspar, C Costa, et al.
Neurology|September 1, 1987
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?A M Bonnet, Y Loria, M H Saint-Hilaire, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1987
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systemsM Ruberg, A Villageois, A M Bonnet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1989
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?B Pillon, B Dubois, G Cusimano, et al.
Advances in Neurology|January 1, 1988
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystoniaM Ruberg, A Villageois, A M Bonnet, et al.
Neurology|March 1, 1997
Low-dose clozapine improves dyskinesias in Parkinson's diseaseF Durif, M Vidailhet, F Assal, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Brain Research|January 1, 1986
Acetylcholinesterase and butyrylcholinesterase in frontal cortex and cerebrospinal fluid of demented and non-demented patients with Parkinson's diseaseM Ruberg, F Rieger, A Villageois, et al.
Lancet (London, England)|March 17, 1979
Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's diseaseY Agid, P Pollak, A M Bonnet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 1, 1995
"Pure" striatonigral degeneration and Parkinson's disease: a comparative clinical studyN Gouider-Khouja, M Vidailhet, A M Bonnet, et al.
Neurology|September 1, 1994
Do parkinsonian symptoms and levodopa-induced dyskinesias start in the foot?M Vidailhet, A M Bonnet, R Marconi, et al.
Advances in Neurology|January 1, 1993
Dementia in Parkinson's disease. Morphometric dataC Duyckaerts, P Gaspar, C Costa, et al.
Neurology|September 1, 1987
Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions?A M Bonnet, Y Loria, M H Saint-Hilaire, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 1, 1987
Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systemsM Ruberg, A Villageois, A M Bonnet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1989
Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?B Pillon, B Dubois, G Cusimano, et al.
Advances in Neurology|January 1, 1988
Acetylcholinesterase and butyrylcholinesterase in cerebrospinal fluid from patients with dystoniaM Ruberg, A Villageois, A M Bonnet, et al.
Neurology|March 1, 1997
Low-dose clozapine improves dyskinesias in Parkinson's diseaseF Durif, M Vidailhet, F Assal, et al.
Pageof 10